| http://www.w3.org/ns/prov#value | - The risk of severe esophageal adverse experiences appears to be greater in patients who lie down after taking oral bisphosphonates including alendronate and/or who fail to swallow oral bisphosphonates including alendronate with the recommended full glass (6 to 8 oz) of water, and/or who continue to take oral bisphosphonates including alendronate after developing symptoms suggestive of esophageal i
|
